The next CR, page-2

First 2 Last

Share
Profile

Follow
Howard Ino

11,974 Posts.

668

22/07/20

18:59

Post #: 46032634
Share

Originally posted by Gerrado ↑

Not saying another CR is necessary... recent product reviews look really encouraging and hopefully orders continue to flow in.

BUT in the event another CR is needed, I really hope management considers returning to their existing shareholders for support.

imo it is the 100's of average punters that put up $10k here and there with no fear of losing it and can tuck it away for a return years away that provide better support than the handful of sophs that appear to walk when their sizable stake drops a few percent.

and worse... we have witnessed the impact of a complex CN loan, which has no concerns for shareholder wealth and appears to currently present an uncomfortable leverage against capital growth. Its really f'ked with genuine holders and after 6 months of bloodshed we are back to where we were just prior and facing a potential overhang of considerable supply.

its the many shareholders that frequent these forums that have likely been critical in helping to keep the lights on in the last raise and should share some considerable credit in nuhearas future successes.

Top stuff nuhearians.

if cash is required, give us first dibs, and some options please.

And preferably right before an OEM, major retailer deal, or inclusion in a national health scheme. Lol.

Seriously though, there is strength in numbers. Best to keep the HC fan base on side. There's some deep pockets here too

Expand

Let's wait and see what Justin's idea of 'overwhelming ' is, before any talk of CR's ?
Income generated from sales, has to kick in, sooner or later..
Not mention, possible cashed up partner ?

NUH Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel